Luxturna gene therapy

Luxturna gene therapy

Credit: OHSU News

Two syringes with the gene therapy treatment Luxturna lie on a table in the surgery suite during Caspian Soto's surgery. Soto, 4, is among the first patients in Oregon to receive a gene therapy approved for inherited vision loss, September 17, 2018 at OHSU Casey Eye Institute. (OHSU/Kristyna Wentz-Graff)

Download Photo (9.3 MB)

Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services X